Cargando…

Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke

Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigo, Gregory, Jaccard, Guy, Tafin Djoko, Donatien, Korneliou, Alexandra, Esposito, Marco, Belushkin, Maxim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811518/
https://www.ncbi.nlm.nih.gov/pubmed/33025067
http://dx.doi.org/10.1007/s00204-020-02924-x
_version_ 1783637515378360320
author Rodrigo, Gregory
Jaccard, Guy
Tafin Djoko, Donatien
Korneliou, Alexandra
Esposito, Marco
Belushkin, Maxim
author_facet Rodrigo, Gregory
Jaccard, Guy
Tafin Djoko, Donatien
Korneliou, Alexandra
Esposito, Marco
Belushkin, Maxim
author_sort Rodrigo, Gregory
collection PubMed
description Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (EC). Long-term effects of these new products on health remain, however, unknown and there is a need to characterize associated potential health risks. The time dedicated to epidemiological data generation (at least 20 to 40 years for cancer endpoint), though, is not compatible with innovative development. Surrogates need, therefore, to be developed. In this work, non-cancer and cancer risks were estimated in a range of HTP and commercial combustible cigarettes based upon their harmful and potentially harmful constituent yields in aerosols and smoke, respectively. It appears that mean lifetime cancer risk values were decreased by more than one order of magnitude when comparing HTPs and commercial cigarettes, and significantly higher margin of exposure for non-cancer risk was observed for HTPs when compared to commercial cigarettes. The same approach was applied to two commercial ECs. Similar results were also found for this category of products. Despite uncertainties related to the factors used for the calculations and methodological limitations, this approach is valuable to estimate health risks associated to the use of innovative products. Moreover, it acts as predictive tool in absence of long-term epidemiological data. Furthermore, both cancer and non-cancer risks estimated for HTPs and ECs highlight the potential of reduced risk for non-combusted products when compared to cigarette smoking. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02924-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7811518
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78115182021-01-25 Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke Rodrigo, Gregory Jaccard, Guy Tafin Djoko, Donatien Korneliou, Alexandra Esposito, Marco Belushkin, Maxim Arch Toxicol Genotoxicity and Carcinogenicity Health risk associated with the use of combustible cigarettes is well characterized and numerous epidemiological studies have been published for many years. Since more than a decade, innovative non-combusted tobacco products have emerged like heated tobacco products (HTP) or electronic cigarettes (EC). Long-term effects of these new products on health remain, however, unknown and there is a need to characterize associated potential health risks. The time dedicated to epidemiological data generation (at least 20 to 40 years for cancer endpoint), though, is not compatible with innovative development. Surrogates need, therefore, to be developed. In this work, non-cancer and cancer risks were estimated in a range of HTP and commercial combustible cigarettes based upon their harmful and potentially harmful constituent yields in aerosols and smoke, respectively. It appears that mean lifetime cancer risk values were decreased by more than one order of magnitude when comparing HTPs and commercial cigarettes, and significantly higher margin of exposure for non-cancer risk was observed for HTPs when compared to commercial cigarettes. The same approach was applied to two commercial ECs. Similar results were also found for this category of products. Despite uncertainties related to the factors used for the calculations and methodological limitations, this approach is valuable to estimate health risks associated to the use of innovative products. Moreover, it acts as predictive tool in absence of long-term epidemiological data. Furthermore, both cancer and non-cancer risks estimated for HTPs and ECs highlight the potential of reduced risk for non-combusted products when compared to cigarette smoking. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02924-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-06 2021 /pmc/articles/PMC7811518/ /pubmed/33025067 http://dx.doi.org/10.1007/s00204-020-02924-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Genotoxicity and Carcinogenicity
Rodrigo, Gregory
Jaccard, Guy
Tafin Djoko, Donatien
Korneliou, Alexandra
Esposito, Marco
Belushkin, Maxim
Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title_full Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title_fullStr Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title_full_unstemmed Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title_short Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
title_sort cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke
topic Genotoxicity and Carcinogenicity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811518/
https://www.ncbi.nlm.nih.gov/pubmed/33025067
http://dx.doi.org/10.1007/s00204-020-02924-x
work_keys_str_mv AT rodrigogregory cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke
AT jaccardguy cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke
AT tafindjokodonatien cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke
AT kornelioualexandra cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke
AT espositomarco cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke
AT belushkinmaxim cancerpotenciesandmarginofexposureusedforcomparativeriskassessmentofheatedtobaccoproductsandelectroniccigarettesaerosolswithcigarettesmoke